On the contrary, more recent in vitro studies on HepG2 cells demonstrated that tamoxifen induction of macrovesicular steatosis is mediated by an enhancement of fatty acid synthesis through the induction of SREBP-1c and its downstream effectors, such as FAS, ACC and SCD [113]. The gene discussed is FAS; the disease is steatosis.